Literature DB >> 28842525

Erratum. Response to Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011. Diabetes Care 2016;39:363-370. Diabetes Care 2017;40:e26.

Ram D Pathak, Emily B Schroeder, Elizabeth R Seaquist, Chan Zeng, Jennifer Elston Lafata, Abraham Thomas, Jean M Lawrence, Andrew J Karter, John F Steiner, Jodi Segal, Patrick J O'Connor.   

Abstract

Entities:  

Year:  2017        PMID: 28842525      PMCID: PMC5606309          DOI: 10.2337/dc17-er10

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
In the article cited above, the duality of interest for author Emily B. Schroeder reads “E.B.S. received industry-sponsored research support from Novartis, Merck Sharpe & Dohme, Boehringer Ingelheim, AstraZeneca, and Bristol-Myers Squibb.” The author has requested that this be corrected to read “E.B.S. was supported by National Institute of Diabetes and Digestive and Kidney Diseases grant K23DK099237.” The online version has been corrected to reflect this change.
  1 in total

1.  Arbutin Alleviates the Liver Injury of α-Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation.

Authors:  Peijie Wu; Ling Qiao; Han Yu; Hui Ming; Chao Liu; Wenjun Wu; Baixue Li
Journal:  Front Cell Dev Biol       Date:  2021-12-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.